1. An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders

   • Nora Vanegas-Arroyave
   • Stanley N. Caroff
   • Samantha A. Cicero

   Current Opinion Open access 19 March 2024 Pages: 239 - 254

   

2. Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options

   • Gemma Mestre-Bach
   • Marc N. Potenza

   Review Article 14 March 2024 Pages: 255 - 265

3. Magnetic Resonance Imaging Evidence Supporting the Efficacy of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis

   • Rosa Cortese
   • Giovanna Testa
   • Nicola De Stefano

   Review Article Open access 15 March 2024 Pages: 267 - 279

   

4. The Dose-Response Relationship between Opioid Agonist Therapy and Alterations in Pain Pathways in Patients with Opioid Use Disorders: A Cross-Sectional Study

   • Kordula Lang-Illievich
   • Johanna Lang
   • Helmar Bornemann-Cimenti

   Original Research Article Open access 29 February 2024 Pages: 281 - 290

   

5. SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants

   • Andreas W. Wolff
   • Jörg Peine
   • Paul Lingor

   Original Research Article Open access 28 February 2024 Pages: 291 - 302

   

6. Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period

   • Kathrine Bang Madsen
   • Mette Bliddal
   • Xiaoqin Liu

   Original Research Article Open access 15 March 2024 Pages: 303 - 314